Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Kyowa_Kirin
|
| gptkbp:acquisitionYear |
2023
|
| gptkbp:focusesOn |
rare diseases
gene therapy inherited disorders |
| gptkbp:foundedYear |
2015
|
| gptkbp:founder |
gptkb:Andrea_Spezzi
gptkb:Bobby_Gaspar gptkb:Jonathan_Appleby gptkb:Robin_Ali gptkb:Stuart_Naylor |
| gptkbp:headquartersLocation |
gptkb:London
|
| https://www.w3.org/2000/01/rdf-schema#label |
Orchard Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Strimvelis
gptkb:Libmeldy |
| gptkbp:numberOfEmployees |
100-200
|
| gptkbp:operatesIn |
gptkb:United_Kingdom
gptkb:United_States |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:specializesIn |
ex vivo autologous gene therapy
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:ORTX
|
| gptkbp:website |
https://www.orchard-tx.com/
|
| gptkbp:bfsParent |
gptkb:Google_Ventures
|
| gptkbp:bfsLayer |
5
|